← Leaderboards
Patrick M. Lynch
University Of Texas Md Anderson Can Ctr
$3,251,125
Attributed
$3,251,125
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,251,125 · 2
By mechanism
N01$3,251,125 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Xifeng Wu$28,679,533
- Qingyi Wei$12,754,141
- Louise C Strong$10,145,346
- Margaret R Spitz$17,223,484
- Andrew P Feinberg$58,785,687
Others in their field
Top investigators on “Adenomatous Polyps”
- John Anthony Baron · Dartmouth College$19,709,766
- Vadim Backman · Northwestern University$12,057,031
- Michael P Snyder · Yale University$7,375,099
- Anne M McTiernan · Fred Hutchinson Cancer Research Center$6,569,329
- Randall Walter Burt · University Of Utah$6,543,691
- Kenneth W. Kinzler · Johns Hopkins University$6,340,917
Research focus
Adenomatous PolypsClinical ResearchColon NeoplasmsDrug Screening /EvaluationEnzyme InhibitorsGene ExpressionGenetic SusceptibilityHuman SubjectNeoplasm /Cancer ChemotherapyNeoplasm /Cancer GeneticsPreneoplastic StateProstaglandin Endoperoxide Synthase
Grant awards (3)
A THREE ARM PHASE II CHEMOPREVENTION TRIAL IN ADENOMATOUS POLYPOSIS CO-261095040$0
N01 · FY2006 · CA · contact PI
PHASE II CLINICAL TRIAL OF CELECOXIB IN PERSONS WITH GENOTYPE POSITIV-261005126$0
N01 · FY2006 · CN · contact PI
PHASE II CLINICAL TRIAL OF CELECOXIB IN PERSONS WITH GE$3,251,125
N01 · FY2000 · CN